© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
CE: Advanced Melanoma: A Pharmacist’s Guide to Treatment and Patient Management for New and Emerging Drug Therapies
This activity is supported by an educational grant from Merck Sharp & Dohme Corp..
This activity is supported by an educational grant from Merck Sharp & Dohme Corp..
EDUCATIONAL OBJECTIVES
At the completion of this activity, the participant will be able to:
- Explain how genetic mutations and biomarkers influence therapy selection for the treatment of cutaneous melanoma
- Identify appropriate adjuvant therapy for the treatment of a patient with cutaneous melanoma based on patient- and disease-specific factors
- Examine guideline recommendations to appropriately place targeted therapies in a patient’s treatment algorithm for advanced melanoma
- Identify strategies that pharmacists can employ to overcome challenges commonly seen in the management of patients with advanced melanoma
FACULTY
Heather Armbruster, PharmD, BCOP
Specialty Practice Pharmacist, Melanoma
The Ohio State University , James Comprehensive Cancer Center, Columbus, Ohio
TARGET AUDIENCE: Oncology, health-system, and specialty pharmacists
ACTIVITY TYPE: Application
RELEASE DATE: August 14, 2020
EXPIRATION DATE: February 14, 2021
ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours
FEE: This lesson is offered for free at www.pharmacytimes.org.